-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WcgmgEc3AWCcPLxvJxGkbziNiua29dVzGChhH3J88DhOp1N3boTMwrCq7XQaGhgj KACTwRPjEWnfZF+ZKf+zCA== /in/edgar/work/20000612/0001065156-00-000005/0001065156-00-000005.txt : 20000919 0001065156-00-000005.hdr.sgml : 20000919 ACCESSION NUMBER: 0001065156-00-000005 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000531 FILED AS OF DATE: 20000612 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOLECULAR BIOSYSTEMS INC CENTRAL INDEX KEY: 0000719598 STANDARD INDUSTRIAL CLASSIFICATION: [2835 ] IRS NUMBER: 363078632 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4/A SEC ACT: SEC FILE NUMBER: 001-10546 FILM NUMBER: 653334 BUSINESS ADDRESS: STREET 1: 10030 BARNES CANYON RD CITY: SAN DIEGO STATE: CA ZIP: 92121-2789 BUSINESS PHONE: 8588127001 MAIL ADDRESS: STREET 1: 10030 BARNES CANYON ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 COMPANY DATA: COMPANY CONFORMED NAME: DITTRICH HOWARD CENTRAL INDEX KEY: 0001065156 STANDARD INDUSTRIAL CLASSIFICATION: [ ]OFFICER STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4/A BUSINESS ADDRESS: STREET 1: 10070 BARNES CANYON BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 4/A 1 0001.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. 1. Name and Address of Reporting Person(s) Dittrich, Howard 10030 Barnes Canyon Blvd. San Diego, CA 92121 2. Issuer Name and Ticker or Trading Symbol Molecular Biosystems, Inc. (MB) 3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary) 4. Statement for Month/Year 05/00 5. If Amendment, Date of Original (Month/Year) 06/09/00 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [ ] Director [ ] 10% Owner [X] Officer (give title below) [ ] Other (specify below) Vice President, Research, Medical, & Regulatory Affairs 7. Individual or Joint/Group Filing (Check Applicable Line) [X] Form filed by One Reporting Person [ ] Form filed by More than One Reporting Person
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Security 2)Trans- 3.Trans- 4.Securities Acquired(A) 5)Amount of 6) 7)Nature of action action or Disposed of (D) Securities Indirect Date Code A Beneficially D Beneficial (Month/ or Owned at or Ownership Day/Year) Code V Amount D Price End of Month I - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 05/09/00 J 19,101 (1) D 41,373 D Direct Table II (PART 1) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1 through 6) - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Derivative 2)Conversion 3)Trans- 4)Trans- 5)Number of Derivative 6)Date Exercisable and Security or Exercise action action Securities Acquired (A) Expiration Date Price of Date Code or Disposed of (D) Derivative Security Code V A D Exercisable Expiration - ------------------------------------------------------------------------------------------------------------------------------------ Incentive Stock Option (right $0.7188 05/24/00 A 125,000 (2) 05/24/01 05/24/10 to buy) Table II (PART 2) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1,3 and 7 through 11) - ------------------------------------------------------------------------------------------------------------------------------------ 1)Title of Derivative 3)Trans- 7)Title and Amount 8)Price 9)Number of 10) 11)Nature of Security action of Underlying of Deri- Derivative Indirect Date Securities vative Securities D Beneficial Amount or Security Beneficially or Ownership Number of Owned at I - Title Shares End of Month - ------------------------------------------------------------------------------------------------------------------------------------ Incentive Stock Option (right 05/24/00 Common Stock 125,000 125,000 D Direct to buy) Explanation of Responses: (1) Cancellation of shares in satisfaction of tax liability. (2) Option grants vest 25% per year over four years.
SIGNATURE OF REPORTING PERSON /S/ By: Kevin Helmbacher For: Howard Dittrich DATE
-----END PRIVACY-ENHANCED MESSAGE-----